The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Sponsor content
167 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEPEZZA teprotumumab 500 mg injection powder vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial.
-
Prescription medicine registrationActive ingredients: teprotumumab.
-
Prescription medicine registrationActive ingredients: inebilizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard.
-
Prescription medicine registrationActive ingredients: blinatumomab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CORORA denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEROUNT denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEPTARGIS denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.